{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:08:00Z","timestamp":1771002480408,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,8,25]],"date-time":"2013-08-25T00:00:00Z","timestamp":1377388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s11102-013-0509-x","type":"journal-article","created":{"date-parts":[[2013,8,24]],"date-time":"2013-08-24T07:41:30Z","timestamp":1377330090000},"page":"374-380","source":"Crossref","is-referenced-by-count":16,"title":["Cushing\u2019s disease, pseudo-Cushing states and the dexamethasone test: a historical and critical review"],"prefix":"10.1007","volume":"17","author":[{"given":"J.","family":"Lindholm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,25]]},"reference":[{"key":"509_CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1009905808033","volume":"3","author":"J Lindholm","year":"2000","unstructured":"Lindholm J (2000) Cushing\u2019s syndrome: historical aspects. Pituitary 3:97\u2013104","journal-title":"Pituitary"},{"key":"509_CR2","first-page":"1","volume-title":"The pituitary body and its disorders, clinical states produced by disorders of the hypophysis cerebri","author":"H Cushing","year":"1912","unstructured":"Cushing H (1912) The pituitary body and its disorders, clinical states produced by disorders of the hypophysis cerebri. Lippincott, Philadelphia, pp 1\u2013341"},{"key":"509_CR3","first-page":"137","volume":"50","author":"H Cushing","year":"1932","unstructured":"Cushing H (1932) The basophilic adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50:137\u2013195","journal-title":"Bull Johns Hopkins Hosp"},{"key":"509_CR4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1749-6632.1949.tb39874.x","volume":"50","author":"EJ Kepler","year":"1949","unstructured":"Kepler EJ (1949) Cushing\u2019s disease: a primary disorder of the adrenal cortices. Ann NY Acad Sci 50:657\u2013678","journal-title":"Ann NY Acad Sci"},{"key":"509_CR5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.0954-6820.1950.tb12132.x","volume":"137","author":"J Bauer","year":"1950","unstructured":"Bauer J (1950) The so-called Cushing\u2019s syndrome, its history, terminology and differential diagnosis. Acta Med Scand 137:411\u2013416","journal-title":"Acta Med Scand"},{"key":"509_CR6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(53)92414-3","volume":"261","author":"JD Norymberski","year":"1953","unstructured":"Norymberski JD, Stubbs RD, West HE (1953) Assessment of adrenocortical activity by assay of 17-ketogenic steroids in urine. Lancet 261:1276\u20131281","journal-title":"Lancet"},{"key":"509_CR7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0021-9258(18)56408-5","volume":"185","author":"CC Porter","year":"1950","unstructured":"Porter CC, Silber RH (1950) A quantitative color reaction for cortisone and related 17:21-dihydroxy-20-ketosteroids. J Biol Chem 185:201\u2013207","journal-title":"J Biol Chem"},{"key":"509_CR8","first-page":"484","volume":"12","author":"DE Schteingart","year":"1963","unstructured":"Schteingart DE, Gregerman RI, Conn JW (1963) A comparison of the characteristics of increased adrenocortical function in obesity and in Cushing\u2019s syndrome. Metabolism 12:484\u2013497","journal-title":"Metabolism"},{"key":"509_CR9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/bmj.2.5160.1117","volume":"2","author":"CL Cope","year":"1959","unstructured":"Cope CL, Black EG (1959) The reliability of some adrenal function tests. BMJ 2:1117\u20131122","journal-title":"BMJ"},{"key":"509_CR10","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1210\/jcem-24-9-887","volume":"24","author":"WR Beisel","year":"1964","unstructured":"Beisel WR, Cos JJ, Horton R, Chao PY, Forsham PH (1964) Physiology of urinary cortisol. J Clin Endocrinol Metabol 24:887\u2013893","journal-title":"J Clin Endocrinol Metabol"},{"key":"509_CR11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/00365517309082425","volume":"31","author":"J Lindholm","year":"1973","unstructured":"Lindholm J (1973) The urinary excretion of cortisol. Scand J Lab Clin Invest 31:115\u2013118","journal-title":"Scand J Lab Clin Invest"},{"key":"509_CR12","first-page":"249","volume":"86","author":"L Wilkins","year":"1950","unstructured":"Wilkins L, Lewis R, Klein R, Rosenberg E (1950) The suppression of androgen secretion by cortisone in a case of congenital adrenal hyperplasia. Bull Johns Hopkins Hosp 86:249\u2013252","journal-title":"Bull Johns Hopkins Hosp"},{"key":"509_CR13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jama.1952.03680060047013","volume":"150","author":"JW Jailer","year":"1952","unstructured":"Jailer JW, Louchart J, Cahill GF (1952) Adrenal virilism. 1 Diagnostic consideration and treatment. JAMA 150:575\u2013579","journal-title":"JAMA"},{"key":"509_CR14","first-page":"219","volume":"45","author":"A Segaloff","year":"1955","unstructured":"Segaloff A, Gordon D, Horwitt BN (1955) Differential diagnosis of adrenal lesions by the use of intravenous administration of hydrocortisone. J Lab Clin Med 45:219\u2013227","journal-title":"J Lab Clin Med"},{"key":"509_CR15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1172\/JCI102758","volume":"32","author":"JW Jailer","year":"1953","unstructured":"Jailer JW, Louchart JWT, Gold JJ, Knowlton A, Cahill GF (1953) The effect of cortisone on the urinary excretion of 17-ketosteroids in patients with Cushing\u2019s syndrome. J Clin Invest 32:449\u2013451","journal-title":"J Clin Invest"},{"key":"509_CR16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0002-9343(54)90351-4","volume":"16","author":"JW Jailer","year":"1954","unstructured":"Jailer JW, Gold JJ, Wallace EZ (1954) Evaluation of the \u201ccortisone test\u201d as a diagnostic aid in differentiating adrenal hyperplasia from adrenal neoplasia. Am J Med 16:340\u2013345","journal-title":"Am J Med"},{"key":"509_CR17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/bmj.2.4937.457","volume":"2","author":"CL Cope","year":"1955","unstructured":"Cope CL, Harrison RJ (1955) Effect of 9\u03b1-fluoro hydrocortisone on adrenal hyperfunction in Cushing\u2019s syndrome. BMJ 2:457\u2013460","journal-title":"BMJ"},{"key":"509_CR18","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1210\/jcem-20-12-1539","volume":"20","author":"GW Liddle","year":"1960","unstructured":"Liddle GW (1960) Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing\u2019s syndrome. J Clin Endocrinol Metabol 20:1539\u20131560","journal-title":"J Clin Endocrinol Metabol"},{"key":"509_CR19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/archinte.1965.03870020012006","volume":"116","author":"CA Nugent","year":"1965","unstructured":"Nugent CA, Nichols T, Tayler FH (1965) Diagnosis of Cushing\u2019s syndrome: single dose dexamethasone suppression test. Arch Intern Med 116:172\u2013176","journal-title":"Arch Intern Med"},{"key":"509_CR20","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/jama.1965.03090090026005","volume":"193","author":"FC Pavlatos","year":"1965","unstructured":"Pavlatos FC, Smilo RP, Forsham PH (1965) A rapid screening test for Cushing\u2019s syndrome. JAMA 193:720\u2013723","journal-title":"JAMA"},{"key":"509_CR21","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/bmj.289.6453.1188","volume":"289","author":"L Kennedy","year":"1984","unstructured":"Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR (1984) Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing\u2019s syndrome. BMJ (Clin Res Ed) 289:1188\u20131191","journal-title":"BMJ (Clin Res Ed)"},{"key":"509_CR22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1507\/endocrj1954.35.795","volume":"35","author":"E Odagiri","year":"1988","unstructured":"Odagiri E, Demura R, Demura H, Suda T, Ishiwatari N, Abe Y, Jibiki K, Shizume K (1988) The changes in plasma cortisol and urinary free cortisol by an overnight dexamethasone suppression test in patients with Cushing\u2019s disease. Endocrinol Jpn 35:795\u2013802","journal-title":"Endocrinol Jpn"},{"key":"509_CR23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/000456329503200502","volume":"32","author":"JH Barth","year":"1995","unstructured":"Barth JH, Seth J, Howlett TA, Freedman DB (1995) A survey of endocrine function testing by clinical biochemistry laboratories in the UK. Ann Clin Biochem 32:442\u2013449","journal-title":"Ann Clin Biochem"},{"key":"509_CR24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/bmj.2.5518.847","volume":"2","author":"CL Cope","year":"1966","unstructured":"Cope CL (1966) The adrenal cortex in internal medicine I. BMJ 2:847\u2013853","journal-title":"BMJ"},{"key":"509_CR25","first-page":"175","volume":"42","author":"CW Burke","year":"1973","unstructured":"Burke CW, Beardwell CG (1973) Cushing\u2019s syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis. QJM 42:175\u2013204","journal-title":"QJM"},{"key":"509_CR26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2265.1982.tb00733.x","volume":"16","author":"AW Meikle","year":"1982","unstructured":"Meikle AW (1982) Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone. Clin Endocrinol 16:401\u2013408","journal-title":"Clin Endocrinol"},{"key":"509_CR27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1530\/acta.0.0720054","volume":"72","author":"RJ Croughs","year":"1973","unstructured":"Croughs RJ, Docter R, de Jong FH (1973) Comparison of oral and intravenous dexamethasone suppression tests in the differential diagnosis of Cushing\u2019s syndrome. Acta Endocrinol 72:54\u201362","journal-title":"Acta Endocrinol"},{"key":"509_CR28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1056\/NEJM198403083101009","volume":"310","author":"DN Orth","year":"1984","unstructured":"Orth DN (1984) The old and the new in Cushing\u2019s syndrome. N Engl J Med 310:649\u2013657","journal-title":"N Engl J Med"},{"key":"509_CR29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0002-9343(73)90184-8","volume":"55","author":"RL Eddy","year":"1973","unstructured":"Eddy RL, Jones AL, Gilliland PF, Ibarra JD, Thompson JQ, McMurry JF (1973) Cushing\u2019s syndrome: a prospective study of diagnostic methods. Am J Med 55:621\u2013630","journal-title":"Am J Med"},{"key":"509_CR30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1507\/endocrj.52.103","volume":"52","author":"HA Tran","year":"2005","unstructured":"Tran HA, Petrovsky N (2005) Dexamethasone infusion testing in the diagnosis of Cushing\u2019s syndrome. Endocr J 52:103\u2013109","journal-title":"Endocr J"},{"key":"509_CR31","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/bmj.2.5554.740","volume":"2","author":"S McHardy-Young","year":"1967","unstructured":"McHardy-Young S, Harris PWR, Lessof MH, Lyne G (1967) Single-dose dexamethasone suppression test for Cushing\u2019s syndrome. BMJ 2:740\u2013744","journal-title":"BMJ"},{"key":"509_CR32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1749-6632.2002.tb04417.x","volume":"970","author":"LK Nieman","year":"2002","unstructured":"Nieman LK (2002) Diagnostic tests for Cushing\u2019s syndrome. Ann NY Acad Sci 970:112\u2013118","journal-title":"Ann NY Acad Sci"},{"key":"509_CR33","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","volume":"88","author":"G Arnaldi","year":"2003","unstructured":"Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M (2003) Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593\u20135602","journal-title":"J Clin Endocrinol Metab"},{"key":"509_CR34","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1210\/jc.2003-030510","volume":"88","author":"AM Isidori","year":"2003","unstructured":"Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB (2003) Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing\u2019s syndrome. J Clin Endocrinol Metabol 88:5299\u20135306","journal-title":"J Clin Endocrinol Metabol"},{"key":"509_CR35","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","volume":"367","author":"J Newell-Price","year":"2006","unstructured":"Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing\u2019s syndrome. Lancet 367:1605\u20131617","journal-title":"Lancet"},{"key":"509_CR36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11102-007-0079-x","volume":"11","author":"B Kola","year":"2008","unstructured":"Kola B, Grossman AB (2008) Dynamic testing in Cushing\u2019s syndrome. Pituitary 11:155\u2013162","journal-title":"Pituitary"},{"key":"509_CR37","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metabol 93:1526\u20131540","journal-title":"J Clin Endocrinol Metabol"},{"key":"509_CR38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1507\/endocrj.K08E-353","volume":"56","author":"T Suda","year":"2009","unstructured":"Suda T, Kageyama K, Nigawara T, Sakihara S (2009) Evaluation of diagnostic tests for ACTH-dependent Cushing\u2019s syndrome. Endocr J 56:469\u2013476","journal-title":"Endocr J"},{"key":"509_CR39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF00427458","volume":"84","author":"RJ Branconnier","year":"1984","unstructured":"Branconnier RJ, Oxenkrug GF, McIntyre I, Pomara N, Harto NE, Gershon S (1984) Prediction of serum cortisol response to dexamethasone in normal volunteers: a multivariate approach. Psychopharmacology 84:274\u2013275","journal-title":"Psychopharmacology"},{"key":"509_CR40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2265.1992.tb00950.x","volume":"36","author":"J Lindholm","year":"1992","unstructured":"Lindholm J (1992) Endocrine studies in patients with Cushing\u2019s disease before and after treatment. Clin Endocrinol 36:151\u2013159","journal-title":"Clin Endocrinol"},{"key":"509_CR41","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1210\/jc.2003-030207","volume":"89","author":"JW Findling","year":"2004","unstructured":"Findling JW, Raff H, Aron DC (2004) The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing\u2019s syndrome. J Clin Endocrinol Metabol 89:1222\u20131226","journal-title":"J Clin Endocrinol Metabol"},{"key":"509_CR42","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-2006-924281","volume":"114","author":"TC Friedman","year":"2006","unstructured":"Friedman TC (2006) An update on the overnight dexamethasone suppression test for the diagnosis of Cushing\u2019s syndrome: limitations in patients with mild and\/or episodic hypercortisolism. Exp Clin Endocrinol Diabetes 114:356\u2013360","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"509_CR43","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00006842-195607000-00006","volume":"18","author":"F Board","year":"1956","unstructured":"Board F, Wadeson R, Hamburg D (1956) Psychological stress and endocrine functions. Psychosom Med 18:324\u2013333","journal-title":"Psychosom Med"},{"key":"509_CR44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/bmj.3.5613.285","volume":"3","author":"BJ Carroll","year":"1968","unstructured":"Carroll BJ, Martin FI, Davies B (1968) Resistance to suppression by dexamethasone of plasma 11-OHCS levels in severe depressive illness. BMJ 3:285\u2013287","journal-title":"BMJ"},{"key":"509_CR45","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1176\/ajp.143.4.452","volume":"143","author":"A Georgotas","year":"1986","unstructured":"Georgotas A, McCue RE, Kim OM, Hapworth WE, Reisberg B, Stoll PM, Sinaiko E, Fanelli C, Stokes PE (1986) Dexamethasone suppressionin dementia, depression, and normal aging. Am J Psychiatry 143:452\u2013456","journal-title":"Am J Psychiatry"},{"key":"509_CR46","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1192\/bjp.142.5.498","volume":"142","author":"A Coppen","year":"1983","unstructured":"Coppen A, Abou-Saleh M, Milln P, Metcalfe M, Harwood J, Bailey J (1983) Dexamethasone suppression test in depression and other psychiatric illness. Br J Psychiatry 142:498\u2013504","journal-title":"Br J Psychiatry"},{"key":"509_CR47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0025-7125(16)31805-3","volume":"62","author":"PH Gruen","year":"1978","unstructured":"Gruen PH (1978) Endocrine changes in psychiatric diseases. Med Clin N Am 62:285\u2013295","journal-title":"Med Clin N Am"},{"key":"509_CR48","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/eje.1.01828","volume":"152","author":"JP Brouwer","year":"2005","unstructured":"Brouwer JP, Appelhof BC, Hoogendijk WJ, Huyser J, Endert E, Zuketto C, Schene AH, Tijssen JG, Van Dyck R, Wiersinga WM, Fliers E (2005) Thyroid and adrenal axis in major depression: a controlled study in outpatients. Eur J Endocrinol 152:185\u2013191","journal-title":"Eur J Endocrinol"},{"key":"509_CR49","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0006-3223(97)00148-0","volume":"41","author":"A Rush","year":"1997","unstructured":"Rush A, Giles D, Schlesser M, Orsulak P, Weissenburger J, Fulton C, Fairchild C, Roffwarg H (1997) Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression. Biol Psychiatry 41:915\u2013928","journal-title":"Biol Psychiatry"},{"key":"509_CR50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2265.1982.tb03149.x","volume":"16","author":"H Hasselbalch","year":"1982","unstructured":"Hasselbalch H, Selmer J, Sestoft L, Kehlet H (1982) Hypothalamic-pituitary-adrenocortical function in chronic alcoholism. Clin Endocrinol 16:73\u201376","journal-title":"Clin Endocrinol"},{"key":"509_CR51","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2265.1983.tb00020.x","volume":"19","author":"JRE Davis","year":"1983","unstructured":"Davis JRE, Jeffcoate WJ (1983) Lack of effect of ethanol on plasma cortisol in man. Clin Endocrinol 19:461\u2013466","journal-title":"Clin Endocrinol"},{"key":"509_CR52","first-page":"719","volume":"25","author":"MC Bishop","year":"1971","unstructured":"Bishop MC, Ross EJ (1971) Adrenocortical activity in disseminated malignant disease in relation to prognosis. Br J Cancer 25:719\u2013725","journal-title":"Br J Cancer"},{"key":"509_CR53","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/sj.bjc.6690603","volume":"80","author":"PJ Jenkins","year":"1999","unstructured":"Jenkins PJ, Sohaib SA, Trainer PJ, Lister TA, Besser GM, Reznek R (1999) Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy. Br J Cancer 80:1815\u20131819","journal-title":"Br J Cancer"},{"key":"509_CR54","first-page":"151","volume":"77","author":"M Reincke","year":"1993","unstructured":"Reincke M, Allolio B, Wurth G, Winkelmann W (1993) The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. J Clin Endocrinol Metab 77:151\u2013156","journal-title":"J Clin Endocrinol Metab"},{"key":"509_CR55","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00003246-199303000-00018","volume":"21","author":"D Perrot","year":"1993","unstructured":"Perrot D, Bonneton A, Dechaud H, Motin J, Pugeat M (1993) Hypercortisolism in septic shock is not suppressible by dexamethasone infusion. Crit Care Med 21:396\u2013401","journal-title":"Crit Care Med"},{"key":"509_CR56","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/jc.2010-2722","volume":"96","author":"I Chiodini","year":"2011","unstructured":"Chiodini I (2011) Diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab 96:1223\u20131236","journal-title":"J Clin Endocrinol Metab"},{"key":"509_CR57","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.beem.2011.12.006","volume":"26","author":"G Arnaldi","year":"2012","unstructured":"Arnaldi G, Boscaro M (2012) Adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab 26:405\u2013419","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"509_CR58","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1210\/jc.2010-0633","volume":"95","author":"PM Stewart","year":"2010","unstructured":"Stewart PM (2010) Is subclinical Cushing\u2019s syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined. J Clin Endocrinol Metabol 95:2618\u20132620","journal-title":"J Clin Endocrinol Metabol"},{"key":"509_CR59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.7326\/0003-4819-104-2-180","volume":"104","author":"JB Tyrrell","year":"1986","unstructured":"Tyrrell JB, Findling JW, Aron DC, Fitzgerald PA, Forsham PH (1986) An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing\u2019s syndrome. Ann Intern Med 104:180\u2013186","journal-title":"Ann Intern Med"},{"key":"509_CR60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2265.1988.tb00258.x","volume":"29","author":"AB Grossman","year":"1988","unstructured":"Grossman AB, Howlett TA, Perry L, Coy DH, Savage MO, Lavender P, Rees LH, Besser GM (1988) CRF in the differential diagnosis of Cushing\u2019s syndrome: a comparison with the dexamethasone suppression test. Clin Endocrinol 29:167\u2013178","journal-title":"Clin Endocrinol"},{"key":"509_CR61","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/qjmed\/77.2.1113","volume":"77","author":"SB Blunt","year":"1990","unstructured":"Blunt SB, Sandler LM, Burrin JM, Joplin GF (1990) An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing\u2019s syndrome by clinical features: biochemical tests and radiological findings. QJM 77:1113\u20131133","journal-title":"QJM"},{"key":"509_CR62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-2265.1998.00345.x","volume":"48","author":"N Al-Saadi","year":"1998","unstructured":"Al-Saadi N, Diederich S, Oelkers W (1998) A very high dose dexamethasone suppression test for differential diagnosis of Cushing\u2019s syndrome. Clin Endocrinol 48:45\u201351","journal-title":"Clin Endocrinol"},{"key":"509_CR63","first-page":"117","volume":"86","author":"J Lindholm","year":"2001","unstructured":"Lindholm J, Juul S, J\u00f8rgensen JOL, Astrup J, Bjerre P, Hagen C, J\u00f8rgensen J, Kosteljanetz M, Kristensen L\u00d8, Laurberg P, Feldt-Rasmussen U, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing\u2019s syndrome: a population based study. J Clin Endocrinol Metabol 86:117\u2013123","journal-title":"J Clin Endocrinol Metabol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-013-0509-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-013-0509-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-013-0509-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T20:19:48Z","timestamp":1646425188000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-013-0509-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,25]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["509"],"URL":"https:\/\/doi.org\/10.1007\/s11102-013-0509-x","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,25]]}}}